Keith Boivin joins Repertoire board
Keith Boivin, general manager of IMCO Home Care (IHC), has agreed to serve on the Repertoire editorial advisory board. He joined IMCO with over 20 years of experience in the medical device and medical distribution industry. He has held leadership positions in both sectors managing the national accounts, distribution channels, and GPO contracts for some of the largest vendors in their respective markets. Boivin is currently serving on three medical industry boards and resides in Keller, Texas, just north of Fort Worth, with his wife of 15 years, Kim, and their three children – Lila, 13; Wesley, 11; and Delaney, 10.
McKesson to acquire Medical Specialties Distributors for $800M
McKesson Corporation signed a definitive agreement to acquire Medical Specialties Distributors (MSD), a national distributor of infusion and medical-surgical supplies as well as biomedical services to alternate site and home health providers, for $800 million. MSD’s established offering to providers in the home infusion market, as well as technology and services to support customers and patients using these products, will allow McKesson to provide incremental services to other customer segments. The transaction is expected to close in the first half of fiscal 2019, subject to customary closing conditions, including necessary regulatory clearances.
Henry Schein to spin off Animal Health business
Henry Schein Inc (Melville, NY) and Vets First Choice (Portland, MN) announced that Henry Schein will spin off Henry Schein Animal Health (HSAH) and merge it with Vets First Choice. The new company, Vets First Corp will be headquartered in Portland, Maine. Immediately following a spin-off from Henry Schein, HSAH will combine with Vets First Choice to form a new publicly traded company. Ben Shaw, the CEO of Vets First Choice, will become CEO of Vets First Corp. David Shaw, chairman of the board and co-founder of Vets First Choice, as well as founder of IDEXX Laboratories Inc, will be chairman of Vets First Corp. The current management of HSAH and Vets First Choice will have senior roles in Vets First Corp. “Following the spin-off of HSAH as an independent company, Henry Schein will focus on our market-leading dental and medical businesses as we make continued investments for future growth,” said Stanly Bergman, CEO of Henry Schein. Henry Schein shareholders and Henry Schein Animal Health-related parties will own approximately 63% of Vets First Corp. common stock immediately following the transaction, while Vets First Choice investors will own approximately 37% of such stock. Henry Schein expects to receive between $1.0 billion and $1.25 billion in cash on a tax-free basis as part of the transaction. The transaction is expected to close by the end of 2018, subject to customary closing conditions, including customary regulatory approvals.
Hill-Rom names John Groetelaars as president, CEO
Hill-Rom Holdings Inc (Chicago, IL) named John P. Groetelaars as president and CEO of the company, effective May 14, 2018. He succeeds John J. Greisch, who previously announced his intention to retire. Groetelaars will also join Hill-Rom’s board of directors. Groetelaars most recently was EVP and president of the Interventional Segment at BD (Becton, Dickinson and Company), which he joined in December 2017 following its acquisition of C.R. Bard Inc.